| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.17▼ | 8.79▲ | 8.63▲ | 8.12▲ | 7.37▲ |
| MA10 | 9.15▼ | 8.48▲ | 8.35▲ | 7.31▲ | 6.11▲ |
| MA20 | 8.96▲ | 8.21▲ | 8.02▲ | 6.82▲ | 5.87▲ |
| MA50 | 8.53▲ | 7.89▲ | 7.40▲ | 5.69▲ | 5.67▲ |
| MA100 | 8.29▲ | 7.27▲ | 7.05▲ | 5.71▲ | 6.07▲ |
| MA200 | 7.99▲ | 7.05▲ | 6.13▲ | 5.59▲ | 4.23▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | 0.105▲ | 0.093▲ | 0.212▲ | 0.404▲ |
| RSI | 68.770▲ | 80.734▲ | 84.302▲ | 80.767▲ | 73.989▲ |
| STOCH | 61.922 | 85.072▲ | 92.296▲ | 91.236▲ | 74.248 |
| WILL %R | -26.374 | -9.125▲ | -7.038▲ | -3.816▲ | -2.492▲ |
| CCI | 26.093 | 175.026▲ | 210.839▲ | 181.937▲ | 217.445▲ |
|
Friday, May 08, 2026 01:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Monday, May 04, 2026 05:06 AM
PM ET; NEEDHAM, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL ...
|
|
Wednesday, April 29, 2026 08:08 AM
Candel Therapeutics Inc (NASDAQ:CADL), a clinical-stage biopharmaceutical company developing multimodal immunotherapies for cancer patients, has signed a commercialization agreement with EVERSANA, a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/05/26 | 8.505 | 9.255 | 8.505 | 9.135 | 1,407,501 |
| 08/05/26 | 7.875 | 8.36 | 7.77 | 8.35 | 2,533,636 |
| 07/05/26 | 7.58 | 7.91 | 7.37 | 7.79 | 2,338,482 |
| 06/05/26 | 7.63 | 7.925 | 7.50 | 7.63 | 1,831,107 |
| 05/05/26 | 7.56 | 7.9884 | 7.49 | 7.67 | 2,706,142 |
| 04/05/26 | 6.57 | 7.54 | 6.55 | 7.53 | 2,538,561 |
| 01/05/26 | 6.15 | 6.52 | 6.11 | 6.47 | 1,594,678 |
| 30/04/26 | 6.18 | 6.43 | 6.13 | 6.18 | 1,270,416 |
| 29/04/26 | 6.21 | 6.49 | 6.17 | 6.18 | 1,340,607 |
| 28/04/26 | 6.25 | 6.355 | 6.12 | 6.20 | 647,281 |
|
|
||||
|
|
||||
|
|